Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIb/III Study of MK-0364 in Obese and Overweight Patients
2006-004534-32Phase 2Terminated
- Sponsor
- MSD Finland
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in obesity and class III obesity comparing MK-0364 with Placebo (2 arms). Primary endpoint: Body weight change after 1 year of treatment. Started Sep 2006; status: terminated.
02
Drugs
taranabant
03
Conditions
obesityclass III obesity
Beyond the preview
Go deeper on 2006-004534-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004534-32.